Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-10,021
Closed -$239K – 1434
2024
Q4
$239K Sell
10,021
-3,902
-28% -$109K ﹤0.01% 1183
2024
Q3
$390K Buy
13,923
+650
+5% +$18.4K ﹤0.01% 1015
2024
Q2
$347K Buy
13,273
+114
+0.9% +$2.37K ﹤0.01% 1009
2024
Q1
$288K Buy
13,159
+17
+0.1% +$364 ﹤0.01% 1069
2023
Q4
$306K Buy
13,142
+656
+5% +$13.2K ﹤0.01% 1027
2023
Q3
$246K Buy
+12,486
New +$246K ﹤0.01% 1050

Other funds holding RXO

Glenmede Trust's RXO Position: Q1 2025 in Review

Glenmede Trust sold out of RXO (RXO) in Q1 2025, closing a stake of 10,021 shares — an estimated $239K sold.

Glenmede Trust first reported a position in RXO in Q3 2023 and held it in 6 quarters. The position peaked at $390K in Q3 2024. 258 funds tracked by Wall St. Rank hold RXO as of Q1 2025.

  • Glenmede Trust reported no remaining RXO position as of Q1 2025 after selling out during the quarter.
  • Glenmede Trust sold 10,021 RXO shares in Q1 2025, an estimated $239K.
  • Glenmede Trust first reported a position in RXO in Q3 2023 and held it in 6 quarters.
  • Glenmede Trust's RXO position peaked at $390K in Q3 2024.
  • 258 funds tracked by Wall St. Rank held RXO as of Q1 2025.

Based on Glenmede Trust's 13F filing for Q1 2025, filed 15 May 2025.